MedPath
HSA Approval

VOYDEYA FILM-COATED TABLET 100 MG + 100 MG

SIN17151P

VOYDEYA FILM-COATED TABLET 100 MG + 100 MG

VOYDEYA FILM-COATED TABLET 100 MG + 100 MG

December 26, 2024

ASTRAZENECA SINGAPORE PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantASTRAZENECA SINGAPORE PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

L04AJ09

Manufacturer Information

ASTRAZENECA SINGAPORE PTE LTD

Catalent CTS LLC

Hovione Farmaciencia S.A.

Active Ingredients

Danicopan

100mg

Danicopan

Documents

Package Inserts

Voydeya PI.pdf

Approved: December 26, 2024

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

VOYDEYA FILM-COATED TABLET 100 MG + 100 MG - HSA Approval | MedPath